Deals
Oorja Bio Banks $30M on IPF Drug ORJ-001
Acceleron veterans bet Westlake BioPartners' $30M on ORJ-001, a first-in-class IPF peptide with Phase 1 data in hand and Phase 2 next.
Latest — Page 19
Deals
Commure Raises $70M at $7B, Targets $1T Market
Commure raised $70M at a $7B valuation, with General Catalyst doubling down on AI that automates 85% of hospital billing without human hands.
SEC
Wells Fargo Settles $110M Discrimination Suit
Wells Fargo agreed to a $110M discrimination settlement. The $100M goes to a new mortgage fund, not to the Black homeowners turned away in 2020.
FDA
Paid $1.4B for Sac-TMT, Merck Gets Phase 3 Win
A $1.4B Kelun bet pays off: Merck's sac-TMT is first in a global Phase 3 to beat chemo on OS and PFS in post-platinum endometrial cancer.
SEC
Cut Out: SEC Token Exemption Bypasses Stock Issuers
The SEC's 'innovation exemption' would let platforms tokenize Apple shares without issuer consent, and there's no limit on duplicate wrappers.
AI
Colorado Rewrites AI Law: What Operators Owe by Jan 2027
Colorado's AI Act just shed its discrimination controls; startups dodge impact assessments, but the safe harbor that protected them is gone.
SEC
SEC Kills 50-Year Settlement Gag Rule
Chairman Atkins just gave every company fighting an SEC enforcement action a new weapon: the right to publicly deny while still settling.
Legal
Cut Ring-Fence Rules: UK Treasury Frees £80B
UK Treasury plans to ease ringfencing rules, freeing £80 billion in lending capacity for banks that argued the post-2008 rules cost too much.
Legal
CISA Contractor Leaked GovCloud Keys on GitHub
A CISA contractor disabled GitHub's secret scanning before publishing AWS GovCloud admin keys and plaintext passwords to a public repository.
Legal
Stole 1.8M Fingerprints in NYC Hospital Breach
NYC's largest public health system had fingerprints and palm prints stolen, covering 1.8M people, with no explanation for why it stored biometrics.
Legal
Judge Fines Cliq $6.5M Over 2015 FTC Order
Federal judge fines Cliq $6.5M for violating its 2015 FTC consent order, far below the $52.9M sought, but no receiver and no industry ban.
AI
Summoned by G20, Anthropic Briefs on Mythos Risks
Anthropic will brief the G20's FSB on Mythos, which found thousands of high-severity vulnerabilities leaving many regulators on the outside.
FDA
FDA Cleared Lilly Foundayo in $9.3B Obesity Race
Lilly cleared Foundayo on April 1, but the label carries a required post-market trial for four serious risks, including MACE and liver injury.
FDA
FDA Clears AstraZeneca's Baxfendy, $5B Peak Sales
AstraZeneca's $1.3B CinCor buy paid off: FDA cleared Baxfendy, first-in-class for hypertension, with Leerink's $10B upside scenario on the table.
Deals
Regeneron Commits $125M Upfront in $2.3B Parabilis Deal
Regeneron pays $125M upfront in a $2.3B Parabilis collaboration to build antibody-helicon conjugates, a drug class that doesn't exist yet.
